{
    "2019-04-18": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "earnings",
                        "expected",
                        "grow"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Can Q1 Earnings Lift Healthcare ETFs Higher?",
                "features": {
                    "keywords": [
                        "Q1",
                        "earnings",
                        "healthcare",
                        "ETFs",
                        "lift",
                        "higher"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Here Are the Key Takeaways From J&J's Q1 Earnings Report",
                "features": {
                    "keywords": [
                        "key",
                        "takeaways",
                        "J&J",
                        "Q1",
                        "earnings",
                        "report"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Health Canada Approves SKYRIZI™ (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis",
                "features": {
                    "keywords": [
                        "Health",
                        "Canada",
                        "approves",
                        "SKYRIZI™",
                        "risankizumab",
                        "treatment",
                        "moderate",
                        "severe",
                        "plaque",
                        "psoriasis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}